Results 41 to 50 of about 490,601 (215)

Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer—A Systematic Review [PDF]

Journal of Clinical Medicine, 2019
Survival after potentially curative treatment of gastric cancer remains low, mostly due to peritoneal recurrence. This descriptive review gives an overview of available comparative studies concerning prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with gastric cancer with neither clinically evident metastases nor positive ...
H. J. F. Brenkman, M. Päeva, R. van Hillegersberg, J. P. Ruurda, N. Haj Mohammad   +4 more
openaire   +2 more sources

Successful Implementation of HITOC and HIPEC in the Management of Advanced Ovarian Carcinoma with Pleural and Peritoneal Carcinomatosis

Diagnostics
This case report details the application and outcomes of a novel therapeutic approach involving hyperthermic intraperitoneal chemotherapy (HIPEC) and hyperthermic intrathoracic chemotherapy (HITOC) in a single patient diagnosed with advanced ovarian ...
Bogdan Moldovan, Codin Theodor Saon, Iris-Iuliana Adam, Radu-Mihai Pisica, Vlad Teodor Silaghi, Vlad Untaru, Doly Stoica, Madalina Crisan, Andreea Popianas, Florentina Pescaru, Adriana Zolog, Liliana Vecerzan   +11 more
doaj   +1 more source

No obvious advantage of hyperthermic intraperitoneal chemotherapy after interval debulking surgery in the treatment of advanced ovarian cancer: A retrospective study

Frontiers in Surgery, 2022
ObjectiveTo study the efficacy of interval debulking surgery (IDS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) compared to IDS alone for the treatment of ovarian cancer after neoadjuvant chemotherapy (NACT).MethodsWe conducted a retrospective ...
Mengmeng Lyu, Jin Lu, Yang Shen, Qianqian Chen, Fei Deng, Jinhua Wang   +5 more
doaj   +1 more source

Combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as a treatment for recurrent epithelial ovarian cancer-National Cancer Institute experience

Journal of the Egyptian National Cancer Institute, 2018
Background: Complete cytoreduction has been associated with survival benefit in the treatment of recurrent epithelial ovarian cancer (EOC). In this study, the aim is to investigate the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal ...
Mohamed Ibrahim Fahim, Omaya Abdelhamid Nassar, Osman Mohamed Mansour, Abdelmaksoud Mohamed Ali, Ahmed-Mostafa Mahmoud, Rasha Mahmoud Allam, Amr Kamal   +6 more
doaj   +1 more source

Temperature management during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Frontiers in Oncology, 2023
In addition to attaining complete or near complete cytoreduction, the instillation of select heated chemotherapeutic agents into the abdominal cavity has offered a chance for cure or longer survival inpatients with peritoneal surface malignancies.
Maria F. Ramirez, Juan Jose Guerra-Londono, Pascal Owusu-Agyemang, Keith Fournier, Carlos E. Guerra-Londono   +4 more
doaj   +1 more source

Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points.

, 2014
Comment in Response to: "hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer should be proposed in eight time points". [Eur J Surg Oncol. 2014] Comment on Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic
DE IACO, PIERANDREA, ZAMAGNI, CLAUDIO, PERRONE, ANNA MYRIAM   +2 more
core   +1 more source

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

iNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid, Weirong Fan, Farah Nazir, Yixiang Xing, Tengchuan Jin   +4 more
wiley   +1 more source

Morbidity and Mortality of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients Aged 70 Years and Older: A Two‐Center 10‐Year Experience

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is established for peritoneal surface malignancies, but its use in older patients is debated. We assessed CRS‐HIPEC morbidity and mortality in patients aged ≥ 70 years using a cohort of younger patients as a comparator.
Ali Ediz Kıvanç, Mehmet Oduncu, Pırıltı Özcan, Özgül Düzgün, Neşet Köksal   +4 more
wiley   +1 more source

Concentration‐Based Short‐Course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Cytoreductive Surgery (iCRS) for Advanced Ovarian Cancer: Final Analysis of Overall Survival in a Phase 2 Trial

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background The optimal regimen for Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) remains controversial. We aim to present long‐term overall survival results from our phase 2 trial evaluating a concentration‐based short‐course regimen for ovarian cancer at the time of interval CytoReductive Surgery (iCRS).
Thales Paulo Batista, Ana Beatriz Diniz de Barros, Vandré Cabral Gomes Carneiro, Rodrigo Tancredi, Levon Badiglian‐Filho, Ronaldo Lúcio Rangel Costa, André Lopes, Bruno José de Queiroz Sarmento, Cristiano Souza Leão   +8 more
wiley   +1 more source

Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central‐Eastern European study

Cancer Medicine, 2019
Background and Objectives Clinical experience in Western Europe suggests that cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are promising methods in the management of gastric cancer (GC) with peritoneal metastases ...
Roman Yarema, Jerzy Mielko, Taras Fetsych, Myron Ohorchak, Magdalena Skorzewska, Karol Rawicz‐Pruszyński, Artem Mashukov, Viatcheslav Maksimovsky, Tomasz Jastrzębski, Wojciech Polkowski, Petro Gyrya, Yuriy Kovalchuk, Victor Safiyan, Ivan Karelin, Viatcheslav Kopetskiy, Olena Kolesnik, Yuriy Kondratskiy, Marius Paskonis   +17 more
doaj   +1 more source